Clover Health Stock

The monetary health and increase potentialities of CLOV, display its potential to underperform the marketplace. It currently has a Growth Score of B. Recent price adjustments and income estimate revisions suggest this would be a great stock for momentum traders with a Momentum Score of A.

Clover health stock price forecast

  1. The Clover Health Investments inventory price fell by -0.563% on the remaining day (Friday, 24th Mar 2023) from $zero.89 to $zero.88. During the ultimate buying and selling day the stock fluctuated 2.63% from a day low at $0.88 to a day high of $0.Ninety.

  2. The fee has fallen in 6 of the ultimate 10 days and is down through -three. Forty one% for this period. Volume fell on the last day together with the inventory, that is absolutely a great sign as quantity should follow the inventory.

  3. On the closing day, the buying and selling volume fell through -2 million stocks, and in total, four million stocks were offered and bought for approximately $three.33 million.

CLOV Signals & Forecast

A purchase sign was issued from a pivot backside point on Wednesday, March 22, 2023, and so far it has risen 0.261%.

Further upward thrust is indicated until a brand new pinnacle pivot has been located. Some poor signals have been issued as properly, and these may additionally have a few influences at the close to brief-term development.

The Clover Health Investments stock holds promote alerts from each brief and lengthy-term transferring average giving a more negative forecast for the inventory.

Also, there may be a fashionable sell signal from the relation between the 2 signals in which the long-term common is above the short-time period average.

On corrections up, there will be some resistance from the lines at $0.Ninety-one and $1.07. A spoil-up above any of these tiers will difficult purchase signals.

Furthermore, there’s currently a sell sign from the three-month Moving Average Convergence Divergence (MACD). Volume fell collectively with the charge over the past buying and selling day and this reduces the overall risk as volume must comply with the price actions.

Broker Rating

  • Clover Health Investments, Corp. Currently, has an average brokerage recommendation (ABR) of two.80 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based totally on the actual pointers (Buy, Hold, Sell and so on.) made by 5 brokerage firms.

  • The current ABR compares to an ABR of three.33 a month in the past primarily based on 3-pointers.

  • Of the 5 pointers deriving the present-day ABR, one is Strong Buy, representing 20% of all recommendations. There turned into no Strong Buy or Buy recommendations a month in the past.

Will clover health stock go up

But Hindenburg Research posted a document that claimed Clover and Palihapitiya had misled investors by way of no longer disclosing that the Department of Justice has been investigating its enterprise model.

Following the damning file, CLOV plunged 50% with the aid of the quit of May 2021. But it still drew attention from meme-stock buyers.

Wall Street is positive on Clover Health Investments Corp (CLOV). On average, analysts provide Clover Health Investments Corp a Buy score.

The common price goal is $2.05, this means that analysts anticipate the inventory to climb by way of 68.03% over the subsequent twelve months.

Clover Health Investments Corp (CLOV) inventory has fallen -59. Fifty five% over the last three hundred and sixty-five days and the common rating from Wall Street analysts is a Hold.

InvestorsObserver’s proprietary ranking system offers CLOV inventory a rating of 31 out of a probable one hundred. That rank is mainly inspired by a brief-time period technical rating of three.

Clover Health up sixteen% as hovering Q4 2022 sales boosts optimism

Clover Health Investments (NASDAQ: CLOV) is up 16% in Tuesday afternoon buying and selling after posting an all-at-once strong Q4 2022 sales beat.

Revenue inside the area jumped ~108% as compared to the previous-12 month’s duration to $898.8M (consensus ~$787.5M).

Cowen’s Gary Taylor has a market perform rating and a $1.Seventy-five price goal (52% upside primarily based on Monday’s near), said that while the employer is projecting Medicare Advantage booms above the industry common, it’s below its very own previous year prices because of “a heightened aggressive panorama.”


Medicare Advantage insurance Clover Health published an $84 million loss inside the fourth zone, shrinking its losses yr over year, in step with the organisation’s profits report launched Tuesday. By assessment, Clover mentioned a $187.2 million loss inside the fourth quarter of 2021.

Frequently Asked Questions (FAQs)

Here are a few essential points to know:

Should I purchase or promote Clover Health Investments stock properly now?

4 Wall Street analysts have issued “buy,” “preserve,” and “sell” scores for Clover Health Investments within the remaining year. There are currently 1 sell rating, 2 preserve ratings and 1 purchase score for the inventory. The consensus among Wall Street analysts is that traders should “hold” CLOV shares. A hold rating suggests that analysts consider investors have to hold any present positions they have got in CLOV, however now not buy extra stocks or sell present stocks.

What is Clover Health Investments’ inventory image?

Clover Health Investments trades at the NASDAQ beneath the ticker symbol “CLOV.”

What is Clover Health Investments’ stock price forecast for 2023?

Four Wall Street analysts have issued 12-month charge goals for Clover Health Investments’ shares. Their CLOV share charge forecasts range from $1.25 to $four.00. On common, they assume the enterprise’s share price to reach $2.22 in the next 12 months. This shows a probable upside of 150.9% from the stock’s modern-day charge.

How have CLOV stocks finished in 2023?

Clover Health Investments’ inventory turned into trading at $zero.9295 at the beginning of the 12 months. Since then, CLOV stocks have decreased via 5.Zero% and is now trading at $zero.8834.

When is Clover Health Investments’ next income date?

The corporation is scheduled to launch its next quarterly profits announcement on Monday, May eighth, 2023.

How good deal money does Clover Health Investments make?

Clover Health Investments (NASDAQ: CLOV) has a market capitalization of $423.63 million and generates $3.48 billion in sales every 12 months. The organization earns $-338,840,000.00 in net income (earnings) each yr or ($0.Seventy two) on earnings consistent with a share basis.

How many employees does Clover Health Investments have?

The organization employs 680 people throughout the globe.

What guidance has Clover Health Investments issued on subsequent sector earnings?

Clover Health Investments updated its FY 2023 profits guidance on Wednesday, March, 1st. The enterprise supplied EPS steerage for the period. The agency issued revenue guidance of $1.90 billion-$2.00 billion, in comparison to the consensus revenue estimate of $2.17 billion.

Who are Clover Health Investments’ primary shareholders?

Clover Health Investments’ stock is owned with the aid of a variety of institutional and retail traders. Top institutional traders encompass Geode Capital Management LLC (1.38%), PNC Financial Services Group Inc. (1.17%), Renaissance Technologies LLC (zero.92%), Charles Schwab Investment Management Inc. (zero.54%), Morgan Stanley (zero.22%) and Millennium Management LLC (zero.20%). Insiders that personal organization stock consists of Chamath Palihapitiya, Chelsea Clinton, and Lee Shapiro.


Clover Health Investments, Corp. Operates as a medicare gain insurer inside the United States. The organization thru its Clover Assistant, a software platform that offers preferred company organization and health preservation organization health plans for medicare-eligible customers. It additionally focuses on non-insurance corporations. Clover Health Investments, Corp. Became integrated in 2014 and is primarily based in Franklin, Tennessee.

Related Articles

1. What Do Groundhogs Eat

2. Dolar General Employee Login

3. How is Manuka Honey Beneficial?

Clover Health Stock